Adding glimepiride to current insulin therapy increases high-molecular weight adiponectin levels to improve glycemic control in poorly controlled type 2 diabetes

BACKGROUND: To observe the efficacy and safety of adding glimepiride to established insulin therapy in poorly controlled type 2 diabetes (T2D) and to assess the relationship of changes in the serum high-molecular weight (HMW) adiponectin levels and glycemic control after glimepiride treatment. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chun-Jun, Zhang, Jing-Yun, Yu, De-Min, Zhang, Qiu-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994470/
https://www.ncbi.nlm.nih.gov/pubmed/24650537
http://dx.doi.org/10.1186/1758-5996-6-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994470/
https://www.ncbi.nlm.nih.gov/pubmed/24650537
http://dx.doi.org/10.1186/1758-5996-6-41

Ejemplares similares